Metabolic syndrome and inflammation markers in patients with schizophrenia and recurrent depressive disorder.
نویسندگان
چکیده
BACKGROUND The high prevalence of metabolic syndrome in patients with psychiatric disorders, almost double the prevalence reported for the general population, is worrying. The aim of this study is to investigate the presence of metabolic syndrome and inflammatory marker levels in patients with schizophrenia and recurrent depressive disorder in a Croatian psychiatric sample. SUBJECTS AND METHODS This study included 62 inpatients with schizophrenia and 62 with recurrent depressive disorder treated at the Department of Psychiatry, University Hospital Centre Split, enrolled from November 2011 until May 2012. The cases were compared to 124 healthy subjects from the general population. RESULTS The presence of metabolic syndrome was found in 56.5% of the patients with schizophrenia and 53.2% of the patients with depression, which was significantly more prevalent than in the control group (32.3%). The levels of inflammation markers (i.e., C-reactive protein and PAI-1) were significantly higher among patients with metabolic syndrome. CONCLUSIONS Patients with schizophrenia and recurrent depressive disorder demonstrate a high prevalence of metabolic syndrome that is also related to inflammation processes. In the context of integrative medicine, clinicians and researchers should consider psychiatric patients within a holistic approach.
منابع مشابه
The Effect of Exercise Training on Inflammatory Markers in Patient with Metabolic Syndrome: A Systematic Review and Meta-analysis
Introduction: Metabolic syndrome is associated with an increase in chronic inflammation, in which exercise training may be an effective intervention for the improvement of inflammatory markers. Accordingly, this study aimed to investigate the effect of exercise training on the inflammatory markers of interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), and C-reactive protein (CRP) in pati...
متن کاملEffects of metformin on weight loss and metabolic control in obese patients with schizophrenia and schizoaffective disorder: a randomized, double-blind, controlled clinical trial
Abstract Objective: The effect of metformin on weight changes and some metabolic parameters in patients with schizophrenia and schizoaffective disorder was investigated in this study. Methods: This study, performed during 2018-2019, was a randomized, double-blind, controlled clinical trial. A total of 66 obese patients (BMI≥27) with schizophrenia and schizoaffective disorder, hospitalized in...
متن کاملSerum Adiponectin Level and Clinical, Metabolic, and Hormonal Markers in Patients with Polycystic Ovary Syndrome
متن کامل
A Comparison of Selective Attention Processing in Major Depressive Disorder and Schizophrenia
Objective: Cognitive deficits play an important role in differential diagnostics, prognosis and rehabilitation of people with psychological disorders. Attention problems have profound impact on the therapeutic response, risk of relapse, function and quality of life in people with major depressive disorder and schizophrenia. This study compared selective attention of people with schizophrenia, M...
متن کاملافزودن امگا 3 به درمان نگهدارنده در افسردگی راجعه تک قطبی
Background: Depression is one of the most common psychological disorders. Most depressed patients experience multiple recurrences despite the pharmacologic therapy. Many studies have reported that countries with high rates of fish consumption have low rates of depressive disorder. The aim of present study is to evaluate the effect of omega-3 as a complementary treatment on the patients with r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Psychiatria Danubina
دوره 26 3 شماره
صفحات -
تاریخ انتشار 2014